Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen.

Jelic, S; Radulovic, S; Neskovic-Konstantinovic, Z; Kreacic, M; Ristovic, Z; Bosnjak, S; Milanovic, N; Vuletic, L

Jelic, S; Radulovic, S; Neskovic-Konstantinovic, Z; Kreacic, M; Ristovic, Z; Bosnjak, S; Milanovic, N; Vuletic, L.

Affiliation

Jelic S; Institut za Onkologiju i Radiologiju, Belgrade, Yugoslavia.

Support Care Cancer ; 3(3): 176-82, 1995 May.

Article de En | MEDLINE | ID: mdl-7655778

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Razoxane / Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Doxorubicine / Cyclophosphamide / Fluorouracil / Coeur Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Middle aged Langue: En Journal: Support Care Cancer Sujet du journal: NEOPLASIAS / SERVICOS DE SAUDE Année: 1995 Type de document: Article Pays d'affiliation: Yougoslavie Pays de publication: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links